Curaleaf Holdings (CURLF) Treasury Shares (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Treasury Shares of -$1.0 million for Q2 2024, up 79.84% year-on-year from -$583856.5 in Q3 2023, and down 200.0% on a QoQ basis from $1.0 million in Q4 2023.
Curaleaf Holdings (CURLF) Treasury Shares (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Treasury Shares for 6 consecutive years, with -$1.0 million the latest figure, recorded in Q2 2024.
- Quarterly Treasury Shares rose 79.84% year-over-year to -$1.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$1.0 million (up 79.84% YoY) and the FY2023 annual result came in at $1.0 million, changed N/A from the prior year.
- Treasury Shares declined to -$1.0 million in Q2 2024 per CURLF's latest filing, from $1.0 million in the prior quarter.
- Over the last five years, Treasury Shares for CURLF reached as high as $26.5 million in Q4 2025 and fell as low as $4.3 million in Q4 2022.
- A 4-year average of $10.8 million and a median of $6.2 million in 2023 frame the typical range for Treasury Shares.
- The largest YoY upside for Treasury Shares was 200.0% in 2022 against a maximum downside of 99900.0% in 2022.
- Year by year, Treasury Shares stood at $5.2 million in 2020, then tumbled by 200.0% to -$5.2 million in 2021, then surged by 200.0% to $5.2 million in 2022, then plunged by 79.84% to $1.0 million in 2023, then tumbled by 200.0% to -$1.0 million in 2024.
- According to Business Quant data, Treasury Shares over the past three periods registered -$1.0 million, $1.0 million, and -$5.2 million for Q2 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.55 Mn |
| Dec 31, 2025 | 26.55 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 6.15 Mn |
| Dec 31, 2023 | 6.15 Mn |
| Sep 30, 2023 | -5.21 Mn |
| Sep 30, 2023 | -5.21 Mn |
| Jun 30, 2023 | -5.21 Mn |
| Jun 30, 2023 | -5.21 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | -5.21 Mn |
| Sep 30, 2022 | -5.21 Mn |